The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Expired CME Article

Our Osteoporosis Report Card: ‘A’ for Apathy, ‘D’ for Effort, and ‘F’ for Results

Authors: Ronald C. Hamdy MD, FRCP, FACP

Abstract

Expired CME Article - Our Osteoporosis Report Card: ‘A’ for Apathy, ‘D’ for Effort, and ‘F’ for Results

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Siris ES, Bilezikian JP, Rubin MR, et al. Pins and plaster aren’t enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab 2003;88:3482–3486.
 
2. Kamel HK, Duthie EH. The underuse of therapy in the secondary prevention of hip fractures. Drugs Aging 2002;19:1–10.
 
3. Harrington JT, Broy SB, Derosa AM, et al. Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheum 2002;47:651–654.
 
4. Kiebzak GM, Beinart GA, Perser K, et al. Undertreatment of osteoporosis in men with hip fracture.Arch Intern Med 2002;162:2217–2222.
 
5. Chrischilles EA, Butler CD, Davis CS, et al. A model of lifetime osteoporosis impact. Arch Intern Med1991;151:2026–2032.
 
6. Melton LJ, Chrischilles EA, Cooper C, et al. Perspective. How many women have osteoporosis?J Bone Miner Res 1992;7:1005–1010.
 
7. Ray NF, Chan JK, Thamer M, et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res1997;12:24–35.
 
8. Col NF, Eckman MH, Karas RH, et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA 1997;277:1140–1147.
 
9. Center JR, Nguyen TV, Schneider D, et al. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999;353:878–882.
 
10. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646–650.
 
11. Slagle MA. Medication update. South Med J 2001;94:574–578.
 
12. Hamdy RC. South Med J In press.
 
13. Holick MF. South Med J In press.
 
14. Tanner B. South Med J In press.
 
15. Kanis et al. DXA–diagnostic guidelines for preclinical evaluation and clinical trials in osteoporosis. J Bone Miner Res 1994:9:1137.
 
16. NOF treatment guidelines. National Osteoporosis Foundation. Physicians Guide to Prevention and Treatment of Osteoporosis 2003.
 
17. Bone mass act, July 1998: indications for bone mass measurement coverage. Federal Register1998;63:34320–34328.
 
18. Chrischilles EA, Dasbach EJ, Rubenstein LM, et al. The effect of alendronate on fracture-related healthcare utilization and costs: the fracture intervention trial. Osteoporosis Int 2001;12:654–660.
 
19. Iglesias CP, Torgerson DJ, Bearne A, et al. The cost utility of bisphosphonates treatment in established osteoporosis. QJM 2002;95:305–311.
 
20. Leib ES, Lewiecki EM, Binkley N, et al. Official positions of the international society for clinical densitometry. South Med J 2004;97:107–110